Home » Genzyme Sees No Supply Disruption After FDA Letter
Genzyme Sees No Supply Disruption After FDA Letter
Genzyme Corp said it does not expect production of its biggest-selling drugs to be disrupted by its receipt of a warning letter from U.S. regulators over flaws at one of its manufacturing facilities.
CNN Money
CNN Money
Upcoming Events
-
07May
-
14May
-
30May